LOVELAND, Colo., May 19 /PRNewswire-FirstCall/ -- Heska
Corporation (Nasdaq: HSKA) ("Heska" or the "Company"), a leading
provider of veterinary diagnostic and specialty products, announced
today the first installations of the Company's new
VitalPath™ Blood Gas & Electrolyte Analyzer (the
"VitalPath").
(Logo:
http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO)
Veterinary customers receiving these analyzers have invested in
a major advancement to in-clinic diagnostics. The
VitalPath analyzer delivers accurate results in just 50
seconds for blood gases, electrolytes, and hematocrit, as well as
27 additional calculated parameters. Requiring just under 70
microliters of sample, the VitalPath can be customized to
suit the needs of any clinic.
"We are very pleased to offer the VitalPath analyzer as
an essential part of the veterinary team's in-house laboratory,"
says Michael J. McGinley, President
and Chief Operating Officer of Heska Corporation. "Our customers
have the highest standards for companion animal care and in
emergencies, they depend on fast, accurate results to make
immediate treatment decisions. We are proud to address this
important need with the latest edition to our advanced line-up of
diagnostic blood analyzers."
About Heska
Heska Corporation (Nasdaq: HSKA) sells advanced veterinary
diagnostic and other specialty veterinary products. Heska's
state-of-the-art offerings to its customers include diagnostic
instruments and supplies as well as single use, point-of-care
tests, pharmaceuticals and vaccines. The company's core focus
is on the canine and feline markets where it strives to provide
high value products and unparalleled customer support to
veterinarians. For further information on Heska and its
products, visit the company's website at www.heska.com.
Forward-Looking Statements
This announcement contains forward-looking statements
regarding Heska's future financial and operating results.
These statements are based on current expectations and are
subject to a number of risks and uncertainties. Investors
should note that there is an inherent risk in using past results,
including trends, to predict future outcomes. In addition,
factors that could affect the business and financial results of
Heska generally include the following: uncertainties related to the
performance of products as anticipated over time; uncertainties
related to the timely and level of market acceptance of new
products; risks related to Heska's reliance on third-party
suppliers, which is significant; risks related to the
commercialization of new products; competition; risks related to
Heska's ability to maintain its listing on the NASDAQ Capital
Market; risks related to Heska's ability to market and sell its
products in an economically viable manner; uncertainties related to
the impact of transfer restrictions on Heska's stock, which were
approved by Heska stockholders at Heska's Annual Meeting of
Stockholders on May 4, 2010; and the risks set forth in
Heska's filings and future filings with the Securities and Exchange
Commission, including those set forth in Heska's Quarterly Report
on Form 10-Q for the quarter ended March 31, 2010.
SOURCE Heska Corporation